- Home
- LSTA vs INKT Comparison
LSTA vs INKT Comparison
Compare LSTA & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSTA
- INKT
- Stock Information
- Founded
- LSTA 1980
- INKT 2017
- Country
- LSTA United States
- INKT United States
- Employees
- LSTA N/A
- INKT N/A
- Industry
- LSTA Misc Health and Biotechnology Services
- INKT Medicinal Chemicals and Botanical Products
- Sector
- LSTA Health Care
- INKT Health Care
- Exchange
- LSTA Nasdaq
- INKT Nasdaq
- Market Cap
- LSTA 31.2M
- INKT 36.7M
- IPO Year
- LSTA N/A
- INKT 2021
- Fundamental
- Price
- LSTA $2.55
- INKT $10.10
- Analyst Decision
- LSTA Strong Buy
- INKT Strong Buy
- Analyst Count
- LSTA 1
- INKT 2
- Target Price
- LSTA $15.00
- INKT $6.50
- AVG Volume (30 Days)
- LSTA 24.3K
- INKT 69.9K
- Earning Date
- LSTA 02-27-2025
- INKT 03-20-2025
- Dividend Yield
- LSTA N/A
- INKT N/A
- EPS Growth
- LSTA N/A
- INKT N/A
- EPS
- LSTA N/A
- INKT N/A
- Revenue
- LSTA N/A
- INKT N/A
- Revenue This Year
- LSTA N/A
- INKT N/A
- Revenue Next Year
- LSTA N/A
- INKT N/A
- P/E Ratio
- LSTA N/A
- INKT N/A
- Revenue Growth
- LSTA N/A
- INKT N/A
- 52 Week Low
- LSTA $2.19
- INKT $4.56
- 52 Week High
- LSTA $4.20
- INKT $19.00
- Technical
- Relative Strength Index (RSI)
- LSTA 42.39
- INKT 54.73
- Support Level
- LSTA $2.41
- INKT $8.97
- Resistance Level
- LSTA $2.66
- INKT $9.98
- Average True Range (ATR)
- LSTA 0.19
- INKT 1.44
- MACD
- LSTA 0.01
- INKT -0.07
- Stochastic Oscillator
- LSTA 42.06
- INKT 42.97
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.